2nd Circ. Says Actavis Can't Pull Old Namenda

The Second Circuit upheld an injunction Friday blocking Actavis PLC from pulling an older version of Namenda from shelves before generic drugmakers can launch their own version of the Alzheimer's treatment...

Already a subscriber? Click here to view full article